Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific to Seek Mergers and Acquisitions

09/17/2021 | 09:00am EDT

Thermo Fisher Scientific Inc. (NYSE:TMO) will look for mergers and acquisitions (M&A). Marc Casper, Chairman, President and Chief Executive Officer said, “Our capital deployment strategy, it remains unchanged, and Stephen is going to go through it in more detail. I'm going to focus on M&A, which will be 60% to 75% of our future capital deployment. Looking at our M&A strategy, it's a very successful one. And it's based on the criteria that we use, which is we want to select the right deals, the deals that enhance our customer offering, strengthen our strategic position and ultimately, create shareholder value. It's a very disciplined process on decision-making, and we have a proven integration approach that translates into enhancing the financial and operational performance of the acquired companies. And that translates into excellent cost and revenue synergies and financial performance overall, creating significant value for our shareholders”.


© S&P Capital IQ 2021
All news about THERMO FISHER SCIENTIFIC
05:56aTHERMO FISHER SCIENTIFIC : UK Competition Regulator to Launch Inquiry Into Thermo Fisher's..
MT
12:57aUK Watchdog to Investigate Thermo Fisher's Planned Acquisition of PPD
DJ
10/11THERMO FISHER SCIENTIFIC : to Hold Earnings Conference Call on Wednesday, October 27, 2021
PR
10/07Q LINEA : ASTar launched in Europe
AQ
10/07Thermo Fisher Scientific Officially Launches ASTar for the European Market
CI
10/07Health Care Stocks Gain Premarket Thursday
MT
10/07THERMO FISHER SCIENTIFIC : Prices Notes Offering Totaling 5.25 Billion Euros
MT
10/07Thermo Fisher Scientific and Q-Linea Launch ASTar System, A Rapid Antimicrobial Suscept..
CI
10/06THERMO FISHER SCIENTIFIC : Prices Offering of Euro-Denominated Senior Notes
PR
10/05Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 36 041 M - -
Net income 2021 7 156 M - -
Net Debt 2021 18 490 M - -
P/E ratio 2021 32,3x
Yield 2021 0,17%
Capitalization 227 B 227 B -
EV / Sales 2021 6,82x
EV / Sales 2022 6,15x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 582,39 $
Average target price 642,29 $
Spread / Average Target 10,3%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors